Retroperitoneal lymphadectomy: indications, complications and expectations

Area of Science:

• Oncology
• Surgical Oncology
• Urology

Background:

• Nonseminomatous germ cell tumors (NSGCT) of the testis are a significant concern in male reproductive health.
• Management strategies for NSGCT have evolved, incorporating surgical interventions alongside systemic therapies.
• Retroperitoneal lymphadenectomy (RPLND) plays a role in the multimodal treatment of these tumors.

Purpose of the Study:

• To review the outcomes and complications of retroperitoneal lymphadenectomy in patients with NSGCT.
• To define the indications for RPLND in the context of accurate staging and therapeutic monitoring.
• To assess the impact of RPLND on sexual function and fertility in affected patients.

Main Methods:

• Retrospective review of 152 patients with NSGCT treated with RPLND at Anderson Hospital.
• Analysis of postoperative complications, including wound infections, pancreatitis, lymphocysts, and chylous ascites.
• Evaluation of sexual function (ejaculatory and erectile impotence) and fertility outcomes.

Main Results:

• A complication rate of 6.4% was observed, with specific instances of wound infection, pancreatitis, lymphocyst, and chylous ascites.
• While ejaculatory impotence occurred, 7 out of 12 couples desiring children achieved successful pregnancies.
• No cases of erectile impotence were reported in this patient series.

Conclusions:

• Retroperitoneal lymphadenectomy is a crucial component in the multimodal management of NSGCT.
• The procedure demonstrates a manageable complication profile and preserves erectile function.
• RPLND is valuable for accurate staging, monitoring chemotherapy, and in selected advanced cases.